US Stock MarketDetailed Quotes
MTNB Matinas BioPharma
- 0.7460
- -0.1540-17.11%
Close Nov 12 16:00 ET
- 0.7292
- -0.0168-2.25%
Post 20:01 ET
3.74MMarket Cap-135P/E (TTM)
0.9742High0.6900Low448.19KVolume0.8370Open0.9000Pre Close347.29KTurnover9.17%Turnover RatioLossP/E (Static)5.02MShares21.500052wk High0.20P/B3.65MFloat Cap0.500052wk Low--Dividend TTM4.89MShs Float197.5000Historical High--Div YieldTTM31.58%Amplitude0.5000Historical Low0.7740Avg Price1Lot Size
About Matinas BioPharma Company
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
Company Profile
SymbolMTNB
Company NameMatinas BioPharma
Listing DateMar 2, 2017
Founded2013
CEOMr. Jerome D. Jabbour, J.D.
MarketAMEX
Employees32
Fiscal Year Ends12-31
Address1545 Route 206 South,Suite 302
CityBedminster
ProvinceNew Jersey
CountryUnited States of America
Zip Code07921-9999
Phone1-908-484-8805
Company Executives
- Name
- Position
- Salary
- Jerome D. Jabbour, J.D.
- Chief Executive Officer, President and Director
- 1.67M
- Keith A. Kucinski, C.P.A.,M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Eric J. Ende, M.B.A.,M.D.
- Chairman of the Board
- 151.50K
- Natasha Giordano
- Independent Director
- 137.50K
- Herbert J. Conrad
- Independent Director
- 170.50K
- Dr. Matthew A. Wikler, M.B.A.,M.D.
- Independent Director
- 144.00K
- James S. Scibetta, M.B.A.
- Independent Director
- 155.00K
- Kathryn Penkus Corzo, M.B.A.,R.Ph.
- Independent Director
- 136.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
